Member Info for hawkhead

Why would investors "wait" until just before Phase 3 results to buy thus propelling the SP to 50p to £1 - ish? Who would buy at this SP and not now when the risk of failure is EXACTLY the same as it is now? Anybody on here following that tact? Doesn't make sense to me.

Late signs on Friday point to a great day tomorrow. Not convinced all the buying was down to the Investors Chronicle article - I thought they had a bad reputation? How did their other tips on Friday do? I can't view the article because I'm being asked to subscribe.

",it's people like you who often think outside of the box ,with sky high share price predictions that actually finds that needle in the haystack, and makes them elusive millions £££ if I had of thought like you I would have bought the ASOS group at 7p a share.and sold at its peak of £70 ,,,,,nothing ventured nothing gained"

---------------------------------------------------------------------------------------------------------------------------------------------------

I don't think it quite works out like that, Thomas. I bet there were close to ZERO people who still had ASOS shares when it hit £70n who originally had them at 7p. Likewise, if FUM soared up to a quid I'm sure that the vast majority of PIs in particular would take profits especially if the rise happened on the back of bluster rather than concrete high value contracts because there's always the chance the SP will tumble back to whence it came.

Anyone who tells you a story that they made a thousand percent on a stock will be telling exactly that. A story.

Totally agree, notrac, 15p bid is not budging, looks like a big background seller is providing the Market with all the shares it needs on a kind of "sale or return" basis (ie not forced selling). Has to be Lombard?

Thanks, Tommy.

Not sure what Lombard's strategy is, but they appear to be selling into the strong buying. Maybe they're looking to profit on the substantial number of shares (over 35 million) they bought in the 7p offer. Makes sense.

I see the bid has dropped to 15p like I said it would. Hopefully this will hold, but there is still a heavy seller (Lombard?) stemng the "apparent heavier" recent flurry of buys. There's been sufficent recent volume to suggest an impending Lombard RNS if my thinking is correct.

Thanks, daringinvestor.

Obviously excellent volume getting rid of a glut of profit takers, and as I've said before be braced for another Lombard holdings RNS but I still think there's a significant stake builder in the background..

I wouldn't be surprised if this falls back to 15p today but good consolidation for what I think will be a highly active next week BEFORE the 11/2 presentation so will stick my neck out and say 18p by the end of next week then we'll see what both presentations bring.

PS - Having watched the proactive interview, Ken James came across so much better than Barder ever did, bringing energy and enthusiasm.

I said this would break 15p by the end of the week and it has. Disappointed that no one is humble enough to pat me on the back, so I suppose I'll have to do it myself. "Well Done Hawky".

" I wonder why he was in the US"

------------------------------------------------------

He lives there.

JAMES, Kenneth William
Correspondence address
Surrey Technology Centre, 40 Occam Road Surrey Research Pk, Guildford, Surrey, GU2 7YG
Role Active
Director

Date of birth
May 1952

Appointed on
1 April 2016

Nationality
British

Country of residence
United States

Occupation
Director

datamanman - FUM has uncharacteristically been persistently trading at high volume since the start of the year with only the 1st day back after xmas being below 500k. It's highly unlikely this is due to a high number of PIs diving in and what prompted my already strong view of a stake builder was ironically Lombard's latest dumping RNS. This month they've already offloaded over 4.5 million shares and I reckon we'll get yet another disposal RNS saying they've sold even more. But they're getting outweighed by even heavier buying - I'm guessing a stake builder who'll disclose their holding after 3% aka approx. 6 million shares bought.

Yesterday's wide spread of 13.5p/14.5p also suggested a big buyer / big seller scenario. Don't really now what Lombard's game is, placing IIs usually stick around for at least a medium term objective because they're buying into the idea, rather than trade in and out. Maybe it's complex because their holding is specified as indirect "on behalf of accounts managed on a discretionary basis by Lombard Odier Investment Managers group".

I also think things will hot up MORE, before the presentation on 11/2/19. Thought 15p was going to give today, but convinced it will in the next couple of days.

I don't share your views about Mandy, Rhodi, I find her to be a rude and unpleasant troll whom I've reported (yet again) for being abusive/disruptive. Hopefully others will follow my lead then she'll be banned for constantly causing trouble.

Looks like I'm calling this spot on so far. We should see an upward breakout very shortly..

Whatever it is, it looks likely that there were still lots of questions to be answered following last year's discussions/due diligence before anyone would commit.

I doubt if today's RNS would have attracted many "new" investors as such and I feel today's impressive volume is just a continuance of the recent rise/activity with the usual early morning spike a positive RNS release brings, This is looking good with some relentless buying offsetting Lombard's shedding and the usual profit taking, No let up in sight and I still see 15p being broken by the end of the week, but wouldn't be surprised if this gathers even more steam with a strong breakout..

I think the following part of the RNS might explain why some potential partners had concerns following their own due diligence:

"In addition to the previously reported Phase 2a and pharmacokinetic data presented, which indicated that MED2005 will be likely to have a favourable safety profile in female partners, Futura Medical will present supporting evidence regarding the topical safety of MED2005, based on in vitro impedance testing concluded in late 2018."

Looks like further tests were required to satisfy some parties, so now the following bit of the 26/9/18 interims might kick in:

"Discussions with potential licensees continue in parallel."

Jet7, CSD "was" (and still is) a brilliant innovator for a very bland condom market. Condoms are a necessary evil but CSD could have injected some spark. Shame it all went belly up, but Reckitts saw it as only eating into their own ultra dominance and Church & Dwight decided it would be far too costly to battle against the brand name Durex - and that's where I draw comparisons with MED's impending battle with Viagra, one of the strongest brand names in the world. It won't be easy. I agree MED is more valuable than CSD, but CSD could still have been a very lucrative product for FUM.

An interesting week ahead indeed. Since changing my mind about the sub-10p (because I "see" some stake building) I have acquired 100k shares at a cost of nearly 13 grand, which gave me further scope for testing FUM's "sensitivity". And it confirmed my suspicion that there's a "big" buyer. My initial price target to get shot of my 100k is 25p (giving me some headroom on my overall 30p prediction), but I'll re-assess if the SP doesn't break 15p this week. The Hawk will hold his wing up on Friday if he's wrong, but don't bet on it.

Yes embarrassing indeed. Very embarrassing infact. But not for me. FOR YOU! Further confirms you guys are completely clueless and you should have put more thought into your poor detective work.

2 years ago FUM was a completely different animal, mainly because Church & Dwight had CSD rights for the US and the UK with the prospect of handsome royalties and a milestone payment from an impending launch (as indicated by FUM), a resultant higher profile for FUM and no need for any further placings, not to mention the continued assertions by the management that a MED deal would be closed by the end of the year.

But Church & Dwight;s withdrawal was a major blow and FUM's mangement have since been discredited with lies aboiut a MED deal before the end of 2017 then H1 2018. In summary - CSD now more or less dead and incompetence leading to 70% share dilution. 52p under the circumstances 2 years ago was cheap. Today's DIFFERENT circumstances I reckon 30p is a fair SP especially given FUM's poor management and failed partnerships (see above).

So suck on that guys, and next time you try to discredit my obvious far superior knowledge, then don't be so shoddy. "Must try harder". lol.

PS - Some stake building going on here. Will break 15p this week Listen to the Hawk.

Well, Jet7, it's obvious you just don't get it and you're another ramper living in some dream world. It's alarming that some on here think tiny FUM with a handful of employees is worth nearly a billion quid, when established massive profit making companies at the bottom end of the FTSE100 are worth in the region of 3 to 4 billion quid. You really think someone will pay so much money which might net them approx. £50 million a year profit after all the costs are knocked off the £400 million PEAK annual sales? It'll take them 20 years just to break even LOL.

Come up with some SENSIBLE sums to back up the hundreds of multi million valuations and I might take you seriously, but until then I will view this BB as one populated by a bunch of sad rampers who haven't a clue what they're talking about.

Have a nice weekend.

Rhodi - it's quite obvious Mandy is "not all there". It appears Barder/FUM messed up on the open offer price in that when they decided to go it alone they were hoping/expecting a placing price of 25p a share leading to approx 25% dilution which kind of supports Barder's argument that the decision was made to glean an extra 50% for MED as well as keeping control. So I get that, it's just that the resultant SP crash made the open offer and resultant dilution quite farcical.

The rampers on here predicting a £4.50-ish SP are suggesting FUM will be worth approx. £900 million which means that Barder's extra 50% more value for post Phase 3 could possibly mean there was an offer of £600 million (equating to £5 per share at the time because of the significantly fewer shares). Really? Did FUM turn offers like this down? Of course they didn't.

A more simplistic calculation for me - based on peak annual sales of £400 million which will take some years to achieve, I reckon an average of £200 million will be taken, 10% (maximum) royalties giving £20 million, x 5 years remaining patent (I guess will hit the shelves in 2023, patent expires 2028) = £100 million aka 50p per share max, but will IMO may accept much less (30p IMO) as there are 80 million 7p shares who will be more than happy with a 400% return and many long term shareholders will be glad to get out of this 17 year long nightmare.

So there you have Hawky's reasoning, and remember, rampers, before you start bawling your eyes out that I'm not talking this DOWN but actually predicting a further 230% increase on current SP. Hence my "weak buy" opinion, weak because it's still very high risk (loss making - will go bust if Phase 3 disappoints).

I've no idea what you're talking about, brains.

Anyway, MED has had sufficient coverage in the past year or so for the Market to be fully aware of its potential, so I'm taking the Market's view to be more accurate than a handful of fantasists one here. That is, the SP is riding on an approx. 4 to 1 gamble of Phase 3 success.

The clues usually come when a company has to go cap in hand to the Market for extra funding, and FUM had to go down the "open offer" route because they couldn't get any IIs interested in a placing which tells its own story. And even Lombard are coming across as some kind of short term hedge fund with its jumping in and out, rather than an "end of game believer".

So I'll stick to my guns, FUM might get 100 million absolute max (50p per share) but I'm reckoning 70 million (approx 30p per share) which is still over twice the current SP.

Daringinvestor - I see what you're saying.

My argument is that Viagra is a very strong brand name and it'll be extremely difficult to knock it off its perch no matter how much better MED is. Just like Church & Dwight didn't have the stomach to take on Durex despite having CSD which could have transformed the condom market.

So the gap in the Market isn't big enough for a potential buyer of MED to pay megabucks and maybe this is why FUM took the decision to go alone because the offers pre Phase 3 simply weren't good enough. Even successful Phase 3 will lead to a buy out well short of some peoples expectations. FUM is worth 50p absolute maximum IMO, maybe much less, and with the current incomplete trials the SP is reflecting this.

Some will (of course). But IMO many won't. Just IMO. I wouldn't be surprised if in 10 years time MED isn't even on the Market. despite it's potential. But that's the way the world works.

Daringinvestor - my main argument is that I think some are getting too carried away. It's as though they're saying Viagra is a load of rubbish and the ED Market is crying out for a replacement. They're wrong. Viagra is very effective for many who appear happy with the product. Hey, I could afford a top of the range Audi which is a far smoother drive than my Focus, but I'm happy with what I've got. See?

We'll agree to disagree. The public are generally very cautious and someone who's been taking "tried and trusted" Viagra for years and is happy with the stiffy it gives them, they'll be very tough to budge. "Better" does not always win the day - and anyone who remembers the war between VHS and Betamax will testify.

Don't get me wrong, there's a place for MED, but I don't think it'll get anywhere near Viagra because it's too strong a brand.